nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—breast cancer	0.691	1	CbGaD
Penicillamine—SLCO1B1—Irinotecan—breast cancer	0.0688	0.654	CbGbCtD
Penicillamine—SLCO1B1—Methotrexate—breast cancer	0.0364	0.346	CbGbCtD
Penicillamine—SLCO1B1—Irinotecan Pathway—ABCC1—breast cancer	0.00101	0.0664	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—CYP2D6—breast cancer	0.000959	0.063	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLC28A1—breast cancer	0.000932	0.0612	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—breast cancer	0.000846	0.0555	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—ABCG2—breast cancer	0.000701	0.046	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—breast cancer	0.000685	0.0449	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—BCHE—breast cancer	0.000581	0.0381	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—NCOA2—breast cancer	0.000541	0.0355	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—CYP3A4—breast cancer	0.000541	0.0355	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—breast cancer	0.000463	0.0304	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—NCOA1—breast cancer	0.000456	0.0299	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—breast cancer	0.000375	0.0246	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—breast cancer	0.000374	0.0245	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of organic anions—ALB—breast cancer	0.000332	0.0218	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—APC—breast cancer	0.000315	0.0207	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—NCOA2—breast cancer	0.000283	0.0186	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—ALB—breast cancer	0.000246	0.0162	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—NCOA1—breast cancer	0.000238	0.0156	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.0002	0.0131	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000183	0.012	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000183	0.012	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000152	0.00995	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000139	0.0091	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000133	0.00876	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—ALB—breast cancer	0.000129	0.00844	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—breast cancer	0.000123	0.00808	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000115	0.00754	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000102	0.00667	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	9.78e-05	0.00642	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A10—breast cancer	9.3e-05	0.0061	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC4A7—breast cancer	9.3e-05	0.0061	CbGpPWpGaD
Penicillamine—Dermatitis exfoliative—Doxorubicin—breast cancer	9.15e-05	0.000486	CcSEcCtD
Penicillamine—Anorexia—Gemcitabine—breast cancer	9.14e-05	0.000485	CcSEcCtD
Penicillamine—Vomiting—Vinblastine—breast cancer	9.13e-05	0.000485	CcSEcCtD
Penicillamine—Diarrhoea—Goserelin—breast cancer	9.12e-05	0.000484	CcSEcCtD
Penicillamine—Anaemia—Paclitaxel—breast cancer	9.09e-05	0.000483	CcSEcCtD
Penicillamine—Urethral disorder—Capecitabine—breast cancer	9.09e-05	0.000483	CcSEcCtD
Penicillamine—Urticaria—Thiotepa—breast cancer	9.05e-05	0.000481	CcSEcCtD
Penicillamine—Agitation—Paclitaxel—breast cancer	9.04e-05	0.00048	CcSEcCtD
Penicillamine—Body temperature increased—Thiotepa—breast cancer	9.01e-05	0.000478	CcSEcCtD
Penicillamine—Anorexia—Fluorouracil—breast cancer	8.98e-05	0.000477	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—breast cancer	8.98e-05	0.000477	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Mitoxantrone—breast cancer	8.97e-05	0.000476	CcSEcCtD
Penicillamine—Vomiting—Tamoxifen—breast cancer	8.87e-05	0.000471	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—breast cancer	8.85e-05	0.00047	CcSEcCtD
Penicillamine—Leukopenia—Paclitaxel—breast cancer	8.8e-05	0.000467	CcSEcCtD
Penicillamine—Rash—Tamoxifen—breast cancer	8.79e-05	0.000467	CcSEcCtD
Penicillamine—Hypersensitivity—Vinorelbine—breast cancer	8.79e-05	0.000467	CcSEcCtD
Penicillamine—Dermatitis—Tamoxifen—breast cancer	8.79e-05	0.000467	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Gemcitabine—breast cancer	8.73e-05	0.000464	CcSEcCtD
Penicillamine—Angiopathy—Docetaxel—breast cancer	8.69e-05	0.000461	CcSEcCtD
Penicillamine—Vomiting—Melphalan—breast cancer	8.68e-05	0.000461	CcSEcCtD
Penicillamine—Tinnitus—Capecitabine—breast cancer	8.64e-05	0.000459	CcSEcCtD
Penicillamine—Asthma—Methotrexate—breast cancer	8.62e-05	0.000458	CcSEcCtD
Penicillamine—Rash—Melphalan—breast cancer	8.61e-05	0.000457	CcSEcCtD
Penicillamine—Dermatitis—Melphalan—breast cancer	8.6e-05	0.000457	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Fluorouracil—breast cancer	8.59e-05	0.000456	CcSEcCtD
Penicillamine—Decreased appetite—Mitoxantrone—breast cancer	8.55e-05	0.000454	CcSEcCtD
Penicillamine—Decreased appetite—Irinotecan—breast cancer	8.55e-05	0.000454	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—breast cancer	8.54e-05	0.000453	CcSEcCtD
Penicillamine—Nausea—Vinblastine—breast cancer	8.53e-05	0.000453	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—breast cancer	8.53e-05	0.000453	CcSEcCtD
Penicillamine—Vomiting—Goserelin—breast cancer	8.47e-05	0.00045	CcSEcCtD
Penicillamine—Alopecia—Docetaxel—breast cancer	8.46e-05	0.000449	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—breast cancer	8.45e-05	0.000449	CcSEcCtD
Penicillamine—Angiopathy—Capecitabine—breast cancer	8.41e-05	0.000447	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—breast cancer	8.41e-05	0.000446	CcSEcCtD
Penicillamine—Rash—Goserelin—breast cancer	8.4e-05	0.000446	CcSEcCtD
Penicillamine—Hypersensitivity—Thiotepa—breast cancer	8.4e-05	0.000446	CcSEcCtD
Penicillamine—Dermatitis—Goserelin—breast cancer	8.39e-05	0.000446	CcSEcCtD
Penicillamine—Mental disorder—Docetaxel—breast cancer	8.39e-05	0.000445	CcSEcCtD
Penicillamine—Arthralgia—Paclitaxel—breast cancer	8.37e-05	0.000445	CcSEcCtD
Penicillamine—Anxiety—Paclitaxel—breast cancer	8.34e-05	0.000443	CcSEcCtD
Penicillamine—Decreased appetite—Gemcitabine—breast cancer	8.33e-05	0.000443	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	8.31e-05	0.000442	CcSEcCtD
Penicillamine—Nausea—Tamoxifen—breast cancer	8.29e-05	0.00044	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—breast cancer	8.23e-05	0.000437	CcSEcCtD
Penicillamine—Decreased appetite—Fluorouracil—breast cancer	8.19e-05	0.000435	CcSEcCtD
Penicillamine—Alopecia—Capecitabine—breast cancer	8.19e-05	0.000435	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—breast cancer	8.19e-05	0.000435	CcSEcCtD
Penicillamine—Diarrhoea—Vinorelbine—breast cancer	8.16e-05	0.000434	CcSEcCtD
Penicillamine—Dysgeusia—Docetaxel—breast cancer	8.16e-05	0.000433	CcSEcCtD
Penicillamine—Mental disorder—Capecitabine—breast cancer	8.12e-05	0.000431	CcSEcCtD
Penicillamine—Nausea—Melphalan—breast cancer	8.11e-05	0.000431	CcSEcCtD
Penicillamine—Asthma—Epirubicin—breast cancer	8.07e-05	0.000428	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—breast cancer	7.99e-05	0.000424	CcSEcCtD
Penicillamine—Nausea—Goserelin—breast cancer	7.91e-05	0.00042	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—breast cancer	7.91e-05	0.00042	CcSEcCtD
Penicillamine—Dysgeusia—Capecitabine—breast cancer	7.9e-05	0.00042	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—breast cancer	7.89e-05	0.000419	CcSEcCtD
Penicillamine—Thrombocytopenia—Paclitaxel—breast cancer	7.86e-05	0.000417	CcSEcCtD
Penicillamine—Urticaria—Mitoxantrone—breast cancer	7.82e-05	0.000415	CcSEcCtD
Penicillamine—Diarrhoea—Thiotepa—breast cancer	7.8e-05	0.000414	CcSEcCtD
Penicillamine—Skin disorder—Paclitaxel—breast cancer	7.8e-05	0.000414	CcSEcCtD
Penicillamine—Body temperature increased—Irinotecan—breast cancer	7.78e-05	0.000413	CcSEcCtD
Penicillamine—Body temperature increased—Mitoxantrone—breast cancer	7.78e-05	0.000413	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—breast cancer	7.78e-05	0.000413	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC39A7—breast cancer	7.71e-05	0.00506	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—COX11—breast cancer	7.71e-05	0.00506	CbGpPWpGaD
Penicillamine—Anaemia—Docetaxel—breast cancer	7.7e-05	0.000409	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—breast cancer	7.66e-05	0.000407	CcSEcCtD
Penicillamine—Anorexia—Paclitaxel—breast cancer	7.65e-05	0.000406	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—breast cancer	7.62e-05	0.000405	CcSEcCtD
Penicillamine—Vomiting—Vinorelbine—breast cancer	7.59e-05	0.000403	CcSEcCtD
Penicillamine—Body temperature increased—Gemcitabine—breast cancer	7.58e-05	0.000402	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—breast cancer	7.56e-05	0.000401	CcSEcCtD
Penicillamine—Rash—Vinorelbine—breast cancer	7.52e-05	0.0004	CcSEcCtD
Penicillamine—Dermatitis—Vinorelbine—breast cancer	7.52e-05	0.000399	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—breast cancer	7.49e-05	0.000398	CcSEcCtD
Penicillamine—Urticaria—Fluorouracil—breast cancer	7.49e-05	0.000398	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—breast cancer	7.47e-05	0.000396	CcSEcCtD
Penicillamine—Leukopenia—Docetaxel—breast cancer	7.46e-05	0.000396	CcSEcCtD
Penicillamine—Anaemia—Capecitabine—breast cancer	7.46e-05	0.000396	CcSEcCtD
Penicillamine—Body temperature increased—Fluorouracil—breast cancer	7.45e-05	0.000396	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—breast cancer	7.39e-05	0.000393	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—breast cancer	7.33e-05	0.000389	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—breast cancer	7.32e-05	0.000389	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.31e-05	0.000388	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—breast cancer	7.27e-05	0.000386	CcSEcCtD
Penicillamine—Hypersensitivity—Mitoxantrone—breast cancer	7.25e-05	0.000385	CcSEcCtD
Penicillamine—Hypersensitivity—Irinotecan—breast cancer	7.25e-05	0.000385	CcSEcCtD
Penicillamine—Vomiting—Thiotepa—breast cancer	7.25e-05	0.000385	CcSEcCtD
Penicillamine—Leukopenia—Capecitabine—breast cancer	7.22e-05	0.000384	CcSEcCtD
Penicillamine—Rash—Thiotepa—breast cancer	7.19e-05	0.000382	CcSEcCtD
Penicillamine—Dermatitis—Thiotepa—breast cancer	7.18e-05	0.000381	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—breast cancer	7.17e-05	0.000381	CcSEcCtD
Penicillamine—Arthralgia—Docetaxel—breast cancer	7.1e-05	0.000377	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—breast cancer	7.09e-05	0.000377	CcSEcCtD
Penicillamine—Nausea—Vinorelbine—breast cancer	7.09e-05	0.000376	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—breast cancer	7.07e-05	0.000376	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—breast cancer	7.05e-05	0.000375	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC22A18—breast cancer	7.05e-05	0.00463	CbGpPWpGaD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.05e-05	0.000374	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—breast cancer	7.01e-05	0.000372	CcSEcCtD
Penicillamine—Decreased appetite—Paclitaxel—breast cancer	6.98e-05	0.000371	CcSEcCtD
Penicillamine—Hypersensitivity—Fluorouracil—breast cancer	6.94e-05	0.000369	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—breast cancer	6.94e-05	0.000368	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	6.91e-05	0.00454	CbGpPWpGaD
Penicillamine—Haemorrhage—Methotrexate—breast cancer	6.9e-05	0.000366	CcSEcCtD
Penicillamine—Arthralgia—Capecitabine—breast cancer	6.87e-05	0.000365	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—breast cancer	6.86e-05	0.000364	CcSEcCtD
Penicillamine—Anxiety—Capecitabine—breast cancer	6.85e-05	0.000364	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.82e-05	0.000362	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—breast cancer	6.82e-05	0.000362	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—breast cancer	6.8e-05	0.000361	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A5—breast cancer	6.78e-05	0.00445	CbGpPWpGaD
Penicillamine—Nausea—Thiotepa—breast cancer	6.77e-05	0.000359	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—breast cancer	6.76e-05	0.000359	CcSEcCtD
Penicillamine—Diarrhoea—Irinotecan—breast cancer	6.73e-05	0.000358	CcSEcCtD
Penicillamine—Diarrhoea—Mitoxantrone—breast cancer	6.73e-05	0.000358	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—breast cancer	6.71e-05	0.000357	CcSEcCtD
Penicillamine—Thrombocytopenia—Docetaxel—breast cancer	6.66e-05	0.000354	CcSEcCtD
Penicillamine—Skin disorder—Docetaxel—breast cancer	6.61e-05	0.000351	CcSEcCtD
Penicillamine—Diarrhoea—Gemcitabine—breast cancer	6.56e-05	0.000348	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—breast cancer	6.54e-05	0.000348	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—breast cancer	6.53e-05	0.000347	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—breast cancer	6.49e-05	0.000345	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—breast cancer	6.49e-05	0.000345	CcSEcCtD
Penicillamine—Anorexia—Docetaxel—breast cancer	6.48e-05	0.000344	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	6.48e-05	0.00425	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	6.48e-05	0.00425	CbGpPWpGaD
Penicillamine—Haemorrhage—Epirubicin—breast cancer	6.46e-05	0.000343	CcSEcCtD
Penicillamine—Diarrhoea—Fluorouracil—breast cancer	6.45e-05	0.000342	CcSEcCtD
Penicillamine—Thrombocytopenia—Capecitabine—breast cancer	6.45e-05	0.000342	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—breast cancer	6.43e-05	0.000342	CcSEcCtD
Penicillamine—Skin disorder—Capecitabine—breast cancer	6.4e-05	0.00034	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—breast cancer	6.38e-05	0.000339	CcSEcCtD
Penicillamine—Urticaria—Paclitaxel—breast cancer	6.38e-05	0.000339	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—breast cancer	6.35e-05	0.000337	CcSEcCtD
Penicillamine—Body temperature increased—Paclitaxel—breast cancer	6.34e-05	0.000337	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—breast cancer	6.33e-05	0.000336	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—breast cancer	6.3e-05	0.000334	CcSEcCtD
Penicillamine—Anorexia—Capecitabine—breast cancer	6.28e-05	0.000333	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—breast cancer	6.26e-05	0.000333	CcSEcCtD
Penicillamine—Vomiting—Irinotecan—breast cancer	6.26e-05	0.000332	CcSEcCtD
Penicillamine—Vomiting—Mitoxantrone—breast cancer	6.26e-05	0.000332	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—breast cancer	6.21e-05	0.00033	CcSEcCtD
Penicillamine—Rash—Mitoxantrone—breast cancer	6.2e-05	0.00033	CcSEcCtD
Penicillamine—Rash—Irinotecan—breast cancer	6.2e-05	0.00033	CcSEcCtD
Penicillamine—Dermatitis—Irinotecan—breast cancer	6.2e-05	0.000329	CcSEcCtD
Penicillamine—Dermatitis—Mitoxantrone—breast cancer	6.2e-05	0.000329	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Docetaxel—breast cancer	6.2e-05	0.000329	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HADHB—breast cancer	6.14e-05	0.00403	CbGpPWpGaD
Penicillamine—Alopecia—Methotrexate—breast cancer	6.1e-05	0.000324	CcSEcCtD
Penicillamine—Vomiting—Gemcitabine—breast cancer	6.09e-05	0.000324	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—breast cancer	6.05e-05	0.000321	CcSEcCtD
Penicillamine—Rash—Gemcitabine—breast cancer	6.04e-05	0.000321	CcSEcCtD
Penicillamine—Dermatitis—Gemcitabine—breast cancer	6.04e-05	0.000321	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—breast cancer	6.02e-05	0.00032	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—breast cancer	6.01e-05	0.000319	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Capecitabine—breast cancer	6e-05	0.000319	CcSEcCtD
Penicillamine—Vomiting—Fluorouracil—breast cancer	5.99e-05	0.000318	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—breast cancer	5.98e-05	0.000317	CcSEcCtD
Penicillamine—Rash—Fluorouracil—breast cancer	5.94e-05	0.000316	CcSEcCtD
Penicillamine—Dermatitis—Fluorouracil—breast cancer	5.94e-05	0.000315	CcSEcCtD
Penicillamine—Decreased appetite—Docetaxel—breast cancer	5.91e-05	0.000314	CcSEcCtD
Penicillamine—Hypersensitivity—Paclitaxel—breast cancer	5.91e-05	0.000314	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—breast cancer	5.9e-05	0.000313	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—breast cancer	5.88e-05	0.000312	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—breast cancer	5.86e-05	0.000311	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—breast cancer	5.86e-05	0.000311	CcSEcCtD
Penicillamine—Nausea—Irinotecan—breast cancer	5.85e-05	0.00031	CcSEcCtD
Penicillamine—Nausea—Mitoxantrone—breast cancer	5.85e-05	0.00031	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC39A6—breast cancer	5.84e-05	0.00383	CbGpPWpGaD
Penicillamine—Decreased appetite—Capecitabine—breast cancer	5.73e-05	0.000304	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—breast cancer	5.71e-05	0.000303	CcSEcCtD
Penicillamine—Nausea—Gemcitabine—breast cancer	5.69e-05	0.000302	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—breast cancer	5.66e-05	0.0003	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—FHL2—breast cancer	5.62e-05	0.00369	CbGpPWpGaD
Penicillamine—Nausea—Fluorouracil—breast cancer	5.6e-05	0.000297	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—breast cancer	5.57e-05	0.000296	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—breast cancer	5.55e-05	0.000295	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	5.54e-05	0.00364	CbGpPWpGaD
Penicillamine—Dysgeusia—Epirubicin—breast cancer	5.51e-05	0.000292	CcSEcCtD
Penicillamine—Diarrhoea—Paclitaxel—breast cancer	5.49e-05	0.000292	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—breast cancer	5.42e-05	0.000288	CcSEcCtD
Penicillamine—Body temperature increased—Docetaxel—breast cancer	5.38e-05	0.000286	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—breast cancer	5.38e-05	0.000286	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	5.35e-05	0.00351	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ATP7B—breast cancer	5.34e-05	0.00351	CbGpPWpGaD
Penicillamine—Alopecia—Doxorubicin—breast cancer	5.28e-05	0.00028	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—breast cancer	5.24e-05	0.000278	CcSEcCtD
Penicillamine—Urticaria—Capecitabine—breast cancer	5.23e-05	0.000278	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	5.22e-05	0.00343	CbGpPWpGaD
Penicillamine—Body temperature increased—Capecitabine—breast cancer	5.21e-05	0.000277	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—breast cancer	5.2e-05	0.000276	CcSEcCtD
Penicillamine—Agitation—Epirubicin—breast cancer	5.17e-05	0.000274	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—breast cancer	5.11e-05	0.000272	CcSEcCtD
Penicillamine—Vomiting—Paclitaxel—breast cancer	5.1e-05	0.000271	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—breast cancer	5.09e-05	0.000271	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.08e-05	0.00027	CcSEcCtD
Penicillamine—Rash—Paclitaxel—breast cancer	5.06e-05	0.000269	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	5.06e-05	0.00332	CbGpPWpGaD
Penicillamine—Dermatitis—Paclitaxel—breast cancer	5.06e-05	0.000268	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—breast cancer	5.03e-05	0.000267	CcSEcCtD
Penicillamine—Hypersensitivity—Docetaxel—breast cancer	5.01e-05	0.000266	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCC1—breast cancer	4.97e-05	0.00326	CbGpPWpGaD
Penicillamine—Hypersensitivity—Capecitabine—breast cancer	4.85e-05	0.000258	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—breast cancer	4.81e-05	0.000255	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—breast cancer	4.8e-05	0.000255	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—breast cancer	4.79e-05	0.000254	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—breast cancer	4.78e-05	0.000254	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—breast cancer	4.77e-05	0.000253	CcSEcCtD
Penicillamine—Nausea—Paclitaxel—breast cancer	4.77e-05	0.000253	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—breast cancer	4.76e-05	0.000253	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.75e-05	0.000252	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—breast cancer	4.67e-05	0.000248	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—breast cancer	4.66e-05	0.000247	CcSEcCtD
Penicillamine—Diarrhoea—Docetaxel—breast cancer	4.65e-05	0.000247	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX2—breast cancer	4.65e-05	0.00306	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—breast cancer	4.6e-05	0.00302	CbGpPWpGaD
Penicillamine—Diarrhoea—Capecitabine—breast cancer	4.51e-05	0.000239	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—breast cancer	4.49e-05	0.000239	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—breast cancer	4.49e-05	0.00295	CbGpPWpGaD
Penicillamine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.47e-05	0.000237	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—breast cancer	4.46e-05	0.000237	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—breast cancer	4.43e-05	0.000235	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—breast cancer	4.41e-05	0.000234	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.4e-05	0.000234	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—breast cancer	4.37e-05	0.000232	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—SYNJ2—breast cancer	4.36e-05	0.00286	CbGpPWpGaD
Penicillamine—Vomiting—Docetaxel—breast cancer	4.33e-05	0.00023	CcSEcCtD
Penicillamine—Rash—Docetaxel—breast cancer	4.29e-05	0.000228	CcSEcCtD
Penicillamine—Dermatitis—Docetaxel—breast cancer	4.29e-05	0.000228	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—breast cancer	4.26e-05	0.000226	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TUBB3—breast cancer	4.22e-05	0.00277	CbGpPWpGaD
Penicillamine—Vomiting—Capecitabine—breast cancer	4.19e-05	0.000222	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—breast cancer	4.18e-05	0.000222	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—breast cancer	4.16e-05	0.000221	CcSEcCtD
Penicillamine—Rash—Capecitabine—breast cancer	4.15e-05	0.000221	CcSEcCtD
Penicillamine—Dermatitis—Capecitabine—breast cancer	4.15e-05	0.00022	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—breast cancer	4.12e-05	0.000219	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—NDUFS3—breast cancer	4.05e-05	0.00266	CbGpPWpGaD
Penicillamine—Anorexia—Doxorubicin—breast cancer	4.05e-05	0.000215	CcSEcCtD
Penicillamine—Nausea—Docetaxel—breast cancer	4.04e-05	0.000215	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—breast cancer	3.99e-05	0.000212	CcSEcCtD
Penicillamine—Nausea—Capecitabine—breast cancer	3.91e-05	0.000208	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—breast cancer	3.9e-05	0.000207	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—breast cancer	3.89e-05	0.00256	CbGpPWpGaD
Penicillamine—Body temperature increased—Methotrexate—breast cancer	3.88e-05	0.000206	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.87e-05	0.000205	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—CHST9—breast cancer	3.81e-05	0.0025	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	3.72e-05	0.00244	CbGpPWpGaD
Penicillamine—Decreased appetite—Doxorubicin—breast cancer	3.69e-05	0.000196	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—breast cancer	3.65e-05	0.000194	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—breast cancer	3.63e-05	0.000193	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	3.62e-05	0.00238	CbGpPWpGaD
Penicillamine—Hypersensitivity—Methotrexate—breast cancer	3.61e-05	0.000192	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—COX11—breast cancer	3.61e-05	0.00237	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.55e-05	0.00233	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—breast cancer	3.51e-05	0.00231	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.44e-05	0.00226	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCG2—breast cancer	3.44e-05	0.00226	CbGpPWpGaD
Penicillamine—Hypersensitivity—Epirubicin—breast cancer	3.38e-05	0.00018	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—breast cancer	3.37e-05	0.000179	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—breast cancer	3.36e-05	0.000178	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—breast cancer	3.35e-05	0.000178	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—SHMT1—breast cancer	3.3e-05	0.00217	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CDA—breast cancer	3.3e-05	0.00217	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.26e-05	0.00214	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.23e-05	0.00212	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A5—breast cancer	3.18e-05	0.00209	CbGpPWpGaD
Penicillamine—Diarrhoea—Epirubicin—breast cancer	3.14e-05	0.000167	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—breast cancer	3.13e-05	0.000166	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—breast cancer	3.12e-05	0.000166	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.11e-05	0.00204	CbGpPWpGaD
Penicillamine—Rash—Methotrexate—breast cancer	3.09e-05	0.000164	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—breast cancer	3.09e-05	0.000164	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—APRT—breast cancer	3.07e-05	0.00201	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TFRC—breast cancer	3.07e-05	0.00201	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.01e-05	0.00198	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3e-05	0.00197	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—NCOA2—breast cancer	2.95e-05	0.00194	CbGpPWpGaD
Penicillamine—Vomiting—Epirubicin—breast cancer	2.92e-05	0.000155	CcSEcCtD
Penicillamine—Nausea—Methotrexate—breast cancer	2.91e-05	0.000155	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—breast cancer	2.9e-05	0.000154	CcSEcCtD
Penicillamine—Rash—Epirubicin—breast cancer	2.89e-05	0.000154	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—breast cancer	2.89e-05	0.000153	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—ESRRA—breast cancer	2.89e-05	0.00189	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ANGPTL4—breast cancer	2.89e-05	0.00189	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.82e-05	0.00185	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.74e-05	0.0018	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HADHB—breast cancer	2.74e-05	0.0018	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPI—breast cancer	2.74e-05	0.0018	CbGpPWpGaD
Penicillamine—Nausea—Epirubicin—breast cancer	2.73e-05	0.000145	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.72e-05	0.00179	CbGpPWpGaD
Penicillamine—Vomiting—Doxorubicin—breast cancer	2.7e-05	0.000143	CcSEcCtD
Penicillamine—Rash—Doxorubicin—breast cancer	2.68e-05	0.000142	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—breast cancer	2.67e-05	0.000142	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—ALB—breast cancer	2.64e-05	0.00174	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.62e-05	0.00172	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALDH1A1—breast cancer	2.61e-05	0.00171	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALDH7A1—breast cancer	2.61e-05	0.00171	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.58e-05	0.00169	CbGpPWpGaD
Penicillamine—Nausea—Doxorubicin—breast cancer	2.52e-05	0.000134	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—NME1—breast cancer	2.5e-05	0.00164	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ADSL—breast cancer	2.5e-05	0.00164	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PHGDH—breast cancer	2.5e-05	0.00164	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UMPS—breast cancer	2.5e-05	0.00164	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—FHL2—breast cancer	2.5e-05	0.00164	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—NCOA1—breast cancer	2.49e-05	0.00163	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—BRIP1—breast cancer	2.45e-05	0.00161	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LDHB—breast cancer	2.45e-05	0.00161	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HPSE—breast cancer	2.45e-05	0.00161	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PLG—breast cancer	2.42e-05	0.00159	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA3—breast cancer	2.33e-05	0.00153	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HMMR—breast cancer	2.33e-05	0.00153	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCC1—breast cancer	2.33e-05	0.00153	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARGC1B—breast cancer	2.25e-05	0.00148	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—breast cancer	2.24e-05	0.00147	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.19e-05	0.00144	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.19e-05	0.00144	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—breast cancer	2.15e-05	0.00141	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA4—breast cancer	2.13e-05	0.0014	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CA9—breast cancer	2.13e-05	0.0014	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.1e-05	0.00138	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.08e-05	0.00136	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPX2—breast cancer	2.07e-05	0.00136	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA2—breast cancer	2.07e-05	0.00136	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPX4—breast cancer	2.05e-05	0.00134	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SULT1A1—breast cancer	2.05e-05	0.00134	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA1—breast cancer	2e-05	0.00131	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—IDH1—breast cancer	2e-05	0.00131	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NAT2—breast cancer	1.98e-05	0.0013	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.79e-05	0.00117	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MED12—breast cancer	1.73e-05	0.00114	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—DPYD—breast cancer	1.73e-05	0.00114	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALDOA—breast cancer	1.71e-05	0.00112	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NCOA3—breast cancer	1.66e-05	0.00109	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A2—breast cancer	1.65e-05	0.00108	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.63e-05	0.00107	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCG2—breast cancer	1.61e-05	0.00106	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CPT1A—breast cancer	1.61e-05	0.00106	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MTR—breast cancer	1.61e-05	0.00106	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HPGDS—breast cancer	1.58e-05	0.00104	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HBA1—breast cancer	1.57e-05	0.00103	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ACHE—breast cancer	1.53e-05	0.00101	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTT1—breast cancer	1.53e-05	0.00101	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP17A1—breast cancer	1.45e-05	0.000953	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTGS1—breast cancer	1.44e-05	0.000943	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ENO1—breast cancer	1.44e-05	0.000943	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.43e-05	0.00094	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.41e-05	0.000928	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2D6—breast cancer	1.41e-05	0.000925	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NCOA2—breast cancer	1.38e-05	0.000908	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ALB—breast cancer	1.34e-05	0.000882	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—FASN—breast cancer	1.34e-05	0.00088	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—BCHE—breast cancer	1.34e-05	0.000877	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC5A5—breast cancer	1.32e-05	0.000866	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A1—breast cancer	1.27e-05	0.000836	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NQO1—breast cancer	1.27e-05	0.000836	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.25e-05	0.000819	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP3A4—breast cancer	1.24e-05	0.000816	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.24e-05	0.000812	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP1B1—breast cancer	1.22e-05	0.000802	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—RAF1—breast cancer	1.22e-05	0.000798	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HSP90AA1—breast cancer	1.2e-05	0.000786	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NCOA1—breast cancer	1.17e-05	0.000765	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—STK11—breast cancer	1.15e-05	0.000754	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP19A1—breast cancer	1.15e-05	0.000754	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.08e-05	0.000708	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—COMT—breast cancer	1.07e-05	0.000701	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTP1—breast cancer	1.06e-05	0.000698	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HMOX1—breast cancer	1.05e-05	0.000688	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ITPR1—breast cancer	1.05e-05	0.000686	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCB1—breast cancer	1.01e-05	0.00066	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—TYMS—breast cancer	9.88e-06	0.000649	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTM1—breast cancer	9.77e-06	0.000641	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NCOR1—breast cancer	9.77e-06	0.000641	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PLA2G4A—breast cancer	9.77e-06	0.000641	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPX1—breast cancer	9.35e-06	0.000614	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP1A1—breast cancer	9.26e-06	0.000608	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ERCC2—breast cancer	9.18e-06	0.000603	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MTHFR—breast cancer	8.63e-06	0.000567	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CAV1—breast cancer	7.96e-06	0.000523	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.61e-06	0.000499	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CG—breast cancer	7.25e-06	0.000476	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CD—breast cancer	6.38e-06	0.000418	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALB—breast cancer	6.29e-06	0.000413	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NOS3—breast cancer	6.02e-06	0.000395	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CB—breast cancer	5.56e-06	0.000365	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTGS2—breast cancer	5.51e-06	0.000361	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTEN—breast cancer	4.8e-06	0.000315	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CA—breast cancer	3.39e-06	0.000222	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AKT1—breast cancer	2.77e-06	0.000182	CbGpPWpGaD
